The connection between capital finance, molecular imaging technology and nuclear medicine lies in the fact that these are technology-intensive fields that requires significant investment in equipment, research and development, and ongoing operations. To provide nuclear medicine services, healthcare organizations need to make substantial capital investments in facilities, equipment, and staff. Capital finance, molecular imaging technology and nuclear medicine are intertwined in their mutual dependence on one another. Capital finance provides the necessary resources to invest in these technologies and infrastructure, molecular imaging and nuclear medicine services that require a significant commitment to investment to provide advanced medical care to opportunities not matter what the need. That's where we come in...